CMV Disease and IRIS in HIV-1 Infected Persons
NCT00456664 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2009-02-03
Summary
Various diagnostic methods are available for CMV infection. But none of them could be a standard and highly valuable. Our first goal is to setup a series of molecular diagnostic tools for HIV-1 infected person. By using these tools, physicians can easily select cases with CMV disease or immune restoration inflammatory syndrome (IRIS) to enroll this study. Furthermore, we will seek for a predict marker for CMV reactivation, CMV disease and IRIS. Finally, our research will focus on the mechanism of the IE gene alternative splicing between lytic and latent stage.
Conditions
- HIV Infections
- Cytomegalovirus
Interventions
- GENETIC
-
IE gene
Sponsors & Collaborators
-
Kaohsiung Medical University Chung-Ho Memorial Hospital
lead OTHER
Principal Investigators
-
Jih-Jin Tsai, M.D. · Chung-Ho Memorial Hospital,Kaohsiung Medical University
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-11-30
- Primary Completion
- 2008-07-31
- Completion
- 2008-07-31
Countries
- Taiwan
More Related Trials
-
A Study of Valganciclovir in the Treatment of Cytomegalovirus (CMV) Retinitis in Patients With AIDS
NCT00002222 ·Status: COMPLETED ·Phase: NA
-
A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Eyes
NCT00001062 ·Status: COMPLETED ·Phase: PHASE1
-
A Comparison of ISIS 2922 Used Immediately or Later in Patients With Cytomegalovirus (CMV) of the Eyes
NCT00002355 ·Status: COMPLETED ·Phase: NA
-
A Randomized Controlled Study of the Efficacy and Safety of Maintenance Treatment With Oral Ganciclovir for Newly Diagnosed Cytomegalovirus Retinitis in People With AIDS
NCT00002257 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Elevated CD4 Counts on CMV Retinitis
NCT00091884 ·Status: COMPLETED
-
A Phase I/II Trial to Assess the Safety and Tolerance of Escalating Doses of a Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Retinitis
NCT00002016 ·Status: COMPLETED ·Phase: PHASE1
-
A Pilot Study to Obtain Preliminary Information Regarding the Efficacy and Safety of the Combination of Immune Globulin and Ganciclovir as Compared to Ganciclovir Alone in the Treatment of Sight-Threatening CMV Retinitis in Patients With AIDS
NCT00001999 ·Status: COMPLETED ·Phase: NA
-
Valganciclovir in Patients With CMV Retinitis and AIDS Who Cannot Take Drugs by Injection
NCT00017784 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study of Two Forms of Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS
NCT00002330 ·Status: COMPLETED ·Phase: NA
-
Comparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With AIDS
NCT00001061 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase I/II Open-Labelled Trial of Intravitreal Ganciclovir Salvage Therapy for AIDS Patients With Active CMV Retinitis Who Are Intolerant of Systemic Therapy
NCT00000673 ·Status: COMPLETED ·Phase: PHASE1
-
Ganciclovir Implant Study for Cytomegalovirus Retinitis
NCT00000118 ·Status: COMPLETED ·Phase: PHASE3
-
Foscarnet Treatment of Serious CMV Retinitis Infection in Patients With Acquired Immunodeficiency Syndrome
NCT00000726 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Cidofovir in HIV-Infected Children With Cytomegalovirus (CMV) Disease
NCT00000881 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Study of Viracept in AIDS Patients With Cytomegalovirus Retinitis
NCT00002169 ·Status: COMPLETED ·Phase: PHASE2
-
CMV Retinitis Retreatment Trial
NCT00000766 ·Status: COMPLETED ·Phase: PHASE2
-
Studies of the Ocular Complications of AIDS (SOCA) CMV Retinitis Trial: Foscarnet-Ganciclovir Component
NCT00000665 ·Status: COMPLETED ·Phase: NA
-
A Phase II Dose-Ranging, Open-Labelled Trial of Foscarnet Salvage Therapy for AIDS Patients With Sight-Threatening CMV Retinitis Who Cannot Be Treated With Ganciclovir Due To Myelosuppression or Treatment Failure
NCT00000691 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS
NCT00002432 ·Status: COMPLETED ·Phase: NA
-
A Study of ISIS 2922 in the Treatment of Advanced Cytomegalovirus Retinitis
NCT00002187 ·Status: COMPLETED ·Phase: NA
-
Suppression of Cytomegalovirus Retinitis Utilizing High Dose Intravenous Acyclovir and Oral Zidovudine in Patients With AIDS
NCT00000693 ·Status: COMPLETED ·Phase: NA
-
A Randomized, Controlled Study of the Safety and Preventive Efficacy of Oral Ganciclovir When Used in Conjunction With An Intravitreal Ganciclovir Implant in the Treatment of Cytomegalovirus Retinitis
NCT00002134 ·Status: COMPLETED ·Phase: NA
-
The Safety and Effectiveness of Ganciclovir Used Alone or in Combination With Granulocyte-Macrophage Colony Stimulating Factor in the Treatment of Cytomegalovirus (CMV) of the Eye in Patients With AIDS
NCT00000989 ·Status: COMPLETED ·Phase: NA
-
Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT)
NCT00000143 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Foscarnet Plus Ganciclovir in the Treatment of Cytomegalovirus of the Eye in Patients With AIDS Who Have Already Been Treated With Ganciclovir
NCT00000970 ·Status: COMPLETED ·Phase: PHASE1